Table 3.
Analyses of the association of use of metformin with risk of developing severe dementia.
| HR (95% CI) | p Value | |
|---|---|---|
| Multivariable Adjusted Analysis a | ||
| No metformin use | 1 [Reference] | 1 [Reference] |
| Metformin use | 0.96 (0.63–1.46) | =0.85 |
| Unadjusted Analysis | ||
| No metformin use | 1 [Reference] | 1 [Reference] |
| Metformin use | 0.89 (0.59–1.33) | =0.56 |
Abbreviations: HR, hazard ratio; CI, confidence interval. a Adjusted for age; gender; education level; baseline MMSE score; status of APOE ε4 carrier; diagnosis of hypertension; congestive heart failure; atrial fibrillation; use of dementia medication, antihypertensive medication, and antidepressants.